Amanda Bevan

696 total citations
12 papers, 265 citations indexed

About

Amanda Bevan is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Amanda Bevan has authored 12 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 4 papers in Pediatrics, Perinatology and Child Health and 3 papers in Epidemiology. Recurrent topics in Amanda Bevan's work include Cystic Fibrosis Research Advances (4 papers), Pharmaceutical studies and practices (4 papers) and Respiratory and Cough-Related Research (3 papers). Amanda Bevan is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Pharmaceutical studies and practices (4 papers) and Respiratory and Cough-Related Research (3 papers). Amanda Bevan collaborates with scholars based in United Kingdom and Australia. Amanda Bevan's co-authors include Mark Tighe, Nadeem Afzal, R Mark Beattie, Emma Lim, Saul N. Faust, Andrew Hayen, Gary Connett, Sanjay Patel, Kieran Hand and Helen Green and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Archives of Disease in Childhood and The Pediatric Infectious Disease Journal.

In The Last Decade

Amanda Bevan

10 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Bevan United Kingdom 5 102 92 82 69 29 12 265
Theresa Han‐Markey United States 9 324 3.2× 179 1.9× 50 0.6× 43 0.6× 139 4.8× 18 578
Michael Stenger United States 14 102 1.0× 258 2.8× 97 1.2× 283 4.1× 44 1.5× 38 567
Anne Holdoway United Kingdom 8 23 0.2× 73 0.8× 25 0.3× 31 0.4× 148 5.1× 26 444
Punam Mistry United Kingdom 8 16 0.2× 13 0.1× 140 1.7× 29 0.4× 14 0.5× 9 259
Emma Lim United Kingdom 8 10 0.1× 20 0.2× 117 1.4× 45 0.7× 26 0.9× 24 256
Maria Aparecida Mezzacappa Brazil 10 21 0.2× 39 0.4× 129 1.6× 108 1.6× 38 1.3× 27 241
Devika Dixit Canada 9 49 0.5× 31 0.3× 17 0.2× 42 0.6× 22 0.8× 22 275
Andrea Bollom United States 8 226 2.2× 194 2.1× 33 0.4× 14 0.2× 8 0.3× 8 405
Jessica Buono United States 8 329 3.2× 166 1.8× 10 0.1× 7 0.1× 13 0.4× 16 451
Ana Sant’Anna Canada 10 15 0.1× 53 0.6× 38 0.5× 33 0.5× 89 3.1× 22 240

Countries citing papers authored by Amanda Bevan

Since Specialization
Citations

This map shows the geographic impact of Amanda Bevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Bevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Bevan more than expected).

Fields of papers citing papers by Amanda Bevan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Bevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Bevan. The network helps show where Amanda Bevan may publish in the future.

Co-authorship network of co-authors of Amanda Bevan

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Bevan. A scholar is included among the top collaborators of Amanda Bevan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Bevan. Amanda Bevan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Bevan, Amanda, et al.. (2024). Real-world impact of Elexacaftor-Tezacaftor-Ivacaftor treatment in young people with Cystic Fibrosis: A longitudinal study. Respiratory Medicine. 236. 107882–107882. 1 indexed citations
3.
Bevan, Amanda, et al.. (2024). Elevated liver function tests in infants exposed to elexacaftor-tezacaftor-ivacaftor in utero and while breastfeeding – Case reports. Journal of Cystic Fibrosis. 24(1). 16–18. 1 indexed citations
4.
Patel, Sanjay, Helen Green, Jacqueline S. Gray, et al.. (2020). Evaluating Ceftriaxone 80 mg/kg Administration by Rapid Intravenous Infusion—A Clinical Service Evaluation. The Pediatric Infectious Disease Journal. 40(2). 128–129. 1 indexed citations
6.
Bevan, Amanda, et al.. (2016). AN ELECTRONIC PRESCRIPTION ALERTING SYSTEM-IMPROVING THE DISCHARGE MEDICINES PROCESS. Archives of Disease in Childhood. 101(9). e2.55–e2. 4 indexed citations
7.
Tighe, Mark, et al.. (2014). Pharmacological treatment of children with gastro-oesophageal reflux. Cochrane Database of Systematic Reviews. 2016(11). CD008550–CD008550. 71 indexed citations
8.
Bevan, Amanda, et al.. (2013). Reformulation of standardised neonatal parenteral nutrition to improve nutrient delivery. Archives of Disease in Childhood. 98(6). e1–e1. 1 indexed citations
9.
Merwe, Susanna M. van der, et al.. (2012). Nebulisation of vancomycin injection – efficacy of the nebulisation process for pulmonary delivery. Archives of Disease in Childhood. 97(5). e15.2–e16. 1 indexed citations
10.
Lim, Emma, et al.. (2011). Prescribing for children – taste and palatability affect adherence to antibiotics: a review. Archives of Disease in Childhood. 97(3). 293–297. 125 indexed citations
11.
Bevan, Amanda, et al.. (2011). 112 Can vancomycin injection be nebulised successfully?. Journal of Cystic Fibrosis. 10. S29–S29. 8 indexed citations
12.
Tighe, Mark, Nadeem Afzal, Amanda Bevan, & R Mark Beattie. (2009). Current Pharmacological Management of Gastro-Esophageal Reflux in Children. Pediatric Drugs. 11(3). 185–202. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026